SERVICES
Adoption and adaptation of CPG and clinical pathways
Five key reasons to develop, update, adopt, and adapt CPG to local structures through clinical pathways
- Your doctors will follow management criteria based on the best available evidence
- The best therapeutic options for your patients will be used, in accordance with reasonable algorithms for efficient management
- Your institution will position itself by providing services based on the best evidence
- The use of resources will be optimized given that your institution will work with standardized treatment protocols
- It will ensure that health care is provided comprehensively, continuously, and that the actions carried out by your organization are coordinated and complementary.
Description:
Clinical Practice Guidelines (CPG) are a set of systematically developed recommendations based on the best available evidence, clinical experience, and patient perspectives, to guide health professionals in decision-making in specific clinical circumstances.
However, the development of a CPG implies a technically rigorous and extensive process, which requires approximately 12 to 18 months and the use of significant resources for its completion. Given the availability of high-quality CPGs developed by national and international organizations and in order to avoid duplication of efforts and resources, national or international CPGs are adopted and adapted to the local context, following a rigorous and reproducible methodology.
Considering that new evidence resulting from continuous research is produced, CPGs must include periodic monitoring strategies in order to maintain the validity and quality of the recommendations. Monitoring will be carried out in search of new publications or alerts, which could modify conclusions of previous studies and therefore the recommendations. It is estimated that after a period of two to five years the need for updating the CPC should be assessed.This process will follow a systematic methodology supported by technical resources from the original guide.
In addition, in order to ensure that healthcare is provided comprehensively and continuously and that the actions carried out are coordinated and complementary, clinical pathways are developed. These are tools that organize the necessary management to carry out the initial attention and interventions required by patients, a structured multidisciplinary health care plan that seeks to adapt CPGs to the structure of the organization, detailing the steps that should occur in the course of care and identifying the actors responsible for each one of them.
NeuroEconomix and its Evidence-Based Medicine team offer the most complete and rigorous processes for adapting or adopting CPGs for your institution.
Systematic reviews
The purpose of systematic reviews is to identify, assess and summarize the results of available individual healthcare studies, in relation to a clinical condition, practice or health technology. This allows key information to be available to decision makers, who must have technical arguments when it comes to using a specific technology or making decisions as vital as including one of them or not in the health benefits plan.
They are also an essential part of building a solid proposition of value and an effective access strategy for all manufacturers or technology providers.
Performing these studies will allow you to take part in the generation of knowledge in our country, which has important consequences for the positioning of your organization.
Our team, under its general director Diego Rosselli (H index of 18 in Google Academic and 11 in Scopus), has extensive experience in publishing this type of studies.
Burden of disease studies
These are valuable tools to assess the impact of a disease on the well-being of a population. By quantifying deaths and loss of general health related to a disease, these evaluations allow the system´s stakeholders to understand the impact of a condition and set priorities for the use of resources. They also help to identify needs and opportunities for the development and implementation of health programs and inclusion of new technologies.
These studies can generate awareness of a certain condition in the country.
Real World Studies
Clinical trials are considered the best tool to demonstrate effectiveness and safety of an intervention. However, there is a growing need for “real world evidence”, since the behavior of a technology in a controlled environment, such as a clinical trial, differs from when there is no strict control and follow-up of the intervention.
In this way, a “real world study” can help you identify and construct propositions of value for the client or other decision-makers.
Our team, under its general director Diego Rosselli (H index of 18 in Google Academic and 11 in Scopus), has extensive experience in publishing this type of studies.
Processing of forms for nominations for the Health Benefits Plan
For the inclusion of new technologies, the Ministry of Health of Colombia requires the methodology stablished by the IETS in order to determine the relevance of including such technologies in the benefits plan. For the nomination process a strict series of steps must be followed which include a effectiveness and safety assessment, economic evaluation and budget impact analysis.
Our team has important experience in the completion of these forms and because of the quality of our work, several of the assessed products have been considered by the ministry of health.
In 2018, only 44 technologies which applied for entrance to the health benefits plan passed the IETS quality filter. Of these, 4 were made by NeuroEconomix. The results of the quality assessments of our work made by the IETS are an endorsement of our quality and differential.
Conferences and workshops- NexTalks
Our team has more than 20 years of experience giving workshops, conferences and symposia on relevant topics in the health sector.
We combine the highest standards of technical knowledge with a clear, easy and useful method of communicating key information to the audience, clear and implementable tools according to their needs.
Please do not hesitate to contact us if you would like to communicate and propose ideas to any stakeholder within the health system.
Contact us at asistencia.neuroeconomix@gmail.com
Evidence-based recommendations
Evidence-based recommendations are systematically developed recommendations, based on the best available evidence and clinical experience, adapted to the local context, to guide health professionals in decision-making in particular clinical circumstances.
They allow providers and insurers to guide their health policies according to the best available technical arguments.
Economic studies
One of the biggest challenges facing decision-makers is to optimize the use of health resources. Because of this, the development of economic studies to evaluate health technologies and programs is becoming increasingly relevant and frequent. These help the decision-maker to establish the relevance of including or not including a technology in the system´s budget. Economic evaluations, and especially cost-effectiveness evaluations, are a fundamental tool in this scenario, as they can show both the potential costs and value of the benefits that a technology or program provides, compared to the standard of care. In this way, they can demonstrate the gains or trade-offs of implementing them or not.
These studies have become important tools to build the proposition of value of your product and have an impact on access. NeuroEconomix has extensive experience in the design and development of these types of projects.
Our team, under its general director Diego Rosselli (H index of 18 in Google Academic and 11 in Scopus), has extensive experience in publishing this type of studies.
Online Solutions
With the support of our strategic partner IdeaXplore, we develop data analysis tools with a detailed and intuitive approach, as well as a user-friendly interface for our clients. IPx is a free-use budget impact calculator that will allow you to make calculations and assessments about the entry of a new technology into the country compared to another.
Processing Invima forms
With its extensive experience in conducting studies in epidemiology and pharmacoeconomics and with a detailed knowledge of the health system, NeuroEconomix offers a comprehensive service to process and submit forms to the National Institute of Drug and Food Surveillance (Invima) of Colombia, in order to obtain sanitary registrations or renew existing ones.
The trend in legislative matters, especially Article 72, shows it is increasingly important to consider the pharmacoeconomic aspects from the start when requesting entering a technology into our country. For this reason, you will need a solid interdisciplinary technical team when making these applications.
Our service includes the following:
- Review of legal information in accordance with the requirements of Invima.
- Preparation of legal documents (authorizations, permits, declarations).
- Organization of the dossier for presentation to Invima.
- Presentation and follow-up (periodic) of the process with Invima. Includes preparation of client reports regarding the status of the request for sanitary registration.
- Requesting meetings, if necessary, with the coordinators of the group of medicines and medical devices.
- Notification of the decision at the end of the process.
- Preparation of customer report, if necessary.
Other activities such as:
- Review of advertising material.
- Review of labels and product inserts
- Sanctioning processes (document review, meetings with Invima, response to administrative actions)
- Consultations related to the application of health standards and consumer protection with regard to medicines and medical devices.
